cGAS-STING pathway inhibitor program (Audro BioTech/Eli Lilly)

N/A

Report date: 2025/03/18 18:08:49
NME

Base Information

Drug NamecGAS-STING pathway inhibitor program (Audro BioTech/Eli Lilly)
Drug Alias NameSTING antagonists (Aduro Biotech)STING-Blok (Aduro BioTech/Eli Lilly)cGAS-STING pathway inhibitors (Eli Lilly)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStimulator of interferon genes inhibitors
TargetsStimulator of interferon genes
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChinook Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesChinook Therapeutics Inc
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A